Salmonella typhimurium mediated delivery of apoptin in human laryngeal cancer

International Journal of Medical Sciences

Volumn 10, Issue 12, 2013, Pages 1639-1648

  Guan, Guo fang ^a   Zhao, Ming ^a   Liu, Li Ming ^b   Jin, Chun Shun ^a   Sun, Kai ^a   Zhang, De Jun ^a   Yu, Duo Jiao ^a   Cao, Hong Wei ^a   Lu, Yan Qing ^a   Wen, Lian Ji ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN ACADEMY OF AGRICULTURAL SCIENCES   (China)

Author keywords

Apoptin; Apoptosis; Attenuated salmonella typhimurium; Laryngeal cancer; Tumours specifically therapy

Indexed keywords

APOPTIN; CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BAX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CAPILLARY DENSITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROPORATION; ENZYME ACTIVATION; EXPRESSION VECTOR; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE INSERTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALMONELLA TYPHIMURIUM; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME; WESTERN BLOTTING;

APOPTIN; APOPTOSIS; ATTENUATED SALMONELLA TYPHIMURIUM; LARYNGEAL CANCER; TUMOURS SPECIFICALLY THERAPY;

ANIMALS; APOPTOSIS; CAPSID PROTEINS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LARYNGEAL NEOPLASMS; MICE; SALMONELLA TYPHIMURIUM;

EID: 84884568342     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6960     Document Type: Article

References (40)

1. Wong TS, Gao W, Li ZH, Chan JY, Ho WK. Epigenetic dysregulation in laryngeal squamous cell carcinoma. Journal of oncology. 2012; 739461.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011;61: 69-90.
3. Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngologic clinics of North America. 2008; 41: 673-95.
4. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer. 2007; 110: 1593-601.
5. Hoffmann TK. [Systemic therapy strategies for head-neck carcinomas: current status]. Laryngo- rhino- otologie. 2012;91 Suppl 1: S123-43.
6. Forbes NS. Profile of a bacterial tumour killer. Nat Biotechnol. 2006; 24: 1484-5. doi:nbt1206-1484[pii] 10.1038/nbt1206-1484.
7. Ryan RM GJ, Lewis CE. Use of bacteria in anti-cancer therapies. Bioessays. 2006; 28(1):84-94.
8. Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, Litz C, et al. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer gene therapy. 2003; 10: 737-44.
9. Ganai S, Arenas RB, Forbes NS. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. British journal of cancer. 2009; 101: 1683-91.
10. Jain RK, Forbes NS. Can engineered bacteria help control cancer? Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 14748-50.
11. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, et al. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumour-targeting in vivo. Nature biotechnology. 1999; 17: 37-41.
12. Kasinskas RW, Forbes NS. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumour tissue in vitro. Biotechnology and bioengineering. 2006; 94: 710-21.
13. Forbes NS, Munn LL, Fukumura D, Jain RK. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumours. Cancer research. 2003; 63: 5188-93.
14. Kasinskas RW, Forbes NS. Salmonella typhimurium lacking ribose chemoreceptors localize in tumour quiescence and induce apoptosis. Cancer research. 2007; 67: 3201-9.
15. Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumour microenvironment. Journal of the National Cancer Institute. 2007; 99: 1441-54.
16. Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94: 5843-7.
17. Leliveld SR, Zhang YH, Rohn JL, Noteborn MH, Abrahams JP. Apoptin induces tumour-specific apoptosis as a globular multimer. The Journal of biological chemistry. 2003; 278: 9042-51.
18. Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, Noteborn MH. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer research. 1995; 55: 486-9.
19. Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P, et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annual review of pharmacology and toxicology. 2008; 48: 143-69.
20. Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H. Towards novel paradigms for cancer therapy. Oncogene. 2011;30: 1-20.
21. Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, et al. Intratumoural delivery and suppression of prostate tumour growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer research. 2007; 67: 5859-64.
22. Su J, et al. Inhibition of Dual Specific Oncolytic Adenovirus on Esophageal Cancer via Activation of Caspases by a Mitochondrial-dependent Pathway. Chem Res Chinese Universities. 2012; 28(3): 465-71.
23. Kleinbaum DG, Klein M. Survival Analysis. A self - learning text. Springier; 2005.
24. Lee CH. Engineering bacteria toward tumour targeting for cancer treatment: current state and perspectives. Applied microbiology and biotechnology. 2012;93: 517-23.
25. Paterson Y, Guirnalda PD, Wood LM. Listeria and Salmonella bacterial vectors of tumour-associated antigens for cancer immunotherapy. Seminars in immunology. 2004;22: 183-9.
26. Chantal G., Forest EF., Sebastien C. Sabbagh and Elyse Ferraro,. Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology. 2010; 156: 3689-98.
27. Agorio C, Schreiber F, Sheppard M, Mastroeni P, Fernandez M, Martinez MA, et al. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. The journal of gene medicine. 2007; 9: 416-23.
28. Ryan RM, Green J, Williams PJ, Tazzyman S, Hunt S, Harmey JH, et al. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumours. Gene therapy. 2009; 16: 329-39.
29. Cao HD, Yang YX, Lu L, Liu SN, Wang PL, Tao XH, et al. Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumouri. 2010;96: 296-303.
30. Blache CA, Manuel ER, Kaltcheva TI, Wong AN, Ellenhorn JD, Blazar BR, et al. Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoural vector colonization and suppresses tumour growth. Cancer research. 2012; 72: 6447-56.
31. Guan GF JN, Mi ZQ, Li X, Lian H, Jin CS, Sun LL, Wen LJ. Construction of the nucleic vaccine pVVP3L-18HN and its antitumour effect on human laryngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005; 40(8).
32. Argiris K, Panethymitaki C, Tavassoli M. Naturally occurring, tumour-specific, therapeutic proteins. Experimental biology and medicine. 2012;236: 524-36.
33. Tavassoli M, Guelen L, Luxon BA, Gaken J. Apoptin: specific killer of tumour cells? Apoptosis. 2005; 10: 717-24.
34. Burek M MS, Burek CJ, Daniel PT, Schulze-Osthoff K, Los M. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene. 2006; 25(15): 2213-22.
35. Flora Tzifi CE, et al. The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias. Advances in Hematology. 2012.
36. Shinoura N, Saito K, Yoshida Y, Hashimoto M, Asai A, Kirino T, et al. Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas. Cancer gene therapy. 2000; 7: 739-48.
37. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. Journal of cell science. 2005; 118: 4485-93.
38. Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, Schulze-Osthoff K, et al. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Molecular and cellular biology. 2009; 29: 1235-48.
39. Lee MS, Sun FC, Huang CH, Lien YY, Feng SH, Lai GH, et al. Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumour therapeutic applications. BMC biotechnology. 2012;12: 27.
40. Sorenson B, et al. Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model. Biologics 2010; 4: 61-73.